This content is only available within our institutional offering.
04 May 2016
Lupuzor™ Phase III underway
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Lupuzor™ Phase III underway
ImmuPharma plc (IMM:LON) | 2.2 0 0.5% | Mkt Cap: 9.12m
- Published:
04 May 2016 -
Author:
Dr Mike Mitchell -
Pages:
15